Genome & Company (KOSDAQ:314130)

Genome & Company Statistics

Total Valuation

KOSDAQ:314130 has a market cap or net worth of KRW 230.99 billion. The enterprise value is 226.62 billion.

Market Cap	230.99B
Enterprise Value	226.62B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:314130 has 34.89 million shares outstanding. The number of shares has increased by 2.90% in one year.

Current Share Class	34.89M
Shares Outstanding	34.89M
Shares Change (YoY)	+2.90%
Shares Change (QoQ)	+3.50%
Owned by Insiders (%)	18.51%
Owned by Institutions (%)	15.27%
Float	24.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.39
PB Ratio	2.02
P/TBV Ratio	2.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-35.26
EV / Sales	9.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.14

Financial Position

The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.17.

Current Ratio	2.31
Quick Ratio	1.90
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	-1.02
Interest Coverage	-6.19

Financial Efficiency

Return on equity (ROE) is -7.20% and return on invested capital (ROIC) is -13.81%.

Return on Equity (ROE)	-7.20%
Return on Assets (ROA)	-12.50%
Return on Invested Capital (ROIC)	-13.81%
Return on Capital Employed (ROCE)	-23.89%
Weighted Average Cost of Capital (WACC)	8.28%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.17
Inventory Turnover	1.90

Taxes

Income Tax	-980.96M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +176.35% in the last 52 weeks. The beta is 0.56, so KOSDAQ:314130's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	+176.35%
50-Day Moving Average	7,878.40
200-Day Moving Average	4,781.13
Relative Strength Index (RSI)	37.12
Average Volume (20 Days)	618,248

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:314130 had revenue of KRW 24.59 billion and -6.43 billion in losses. Loss per share was -205.00.

Revenue	24.59B
Gross Profit	13.41B
Operating Income	-29.23B
Pretax Income	-8.67B
Net Income	-6.43B
EBITDA	-22.56B
EBIT	-29.23B
Loss Per Share	-205.00

Balance Sheet

The company has 36.83 billion in cash and 18.97 billion in debt, with a net cash position of 17.86 billion or 511.92 per share.

Cash & Cash Equivalents	36.83B
Total Debt	18.97B
Net Cash	17.86B
Net Cash Per Share	511.92
Equity (Book Value)	114.58B
Book Value Per Share	3,141.79
Working Capital	29.66B

Cash Flow

In the last 12 months, operating cash flow was -18.39 billion and capital expenditures -284.66 million, giving a free cash flow of -18.67 billion.

Operating Cash Flow	-18.39B
Capital Expenditures	-284.66M
Depreciation & Amortization	6.67B
Net Borrowing	-20.77B
Free Cash Flow	-18.67B
FCF Per Share	-535.11

Margins

Gross margin is 54.53%, with operating and profit margins of -118.90% and -26.14%.

Gross Margin	54.53%
Operating Margin	-118.90%
Pretax Margin	-35.25%
Profit Margin	-26.14%
EBITDA Margin	-91.77%
EBIT Margin	-118.90%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:314130 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.90%
Shareholder Yield	-2.90%
Earnings Yield	-2.78%
FCF Yield	-8.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 6, 2024. It was a forward split with a ratio of 2.

Last Split Date	Aug 6, 2024
Split Type	Forward
Split Ratio	2

Scores

KOSDAQ:314130 has an Altman Z-Score of -1.41. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.41
Piotroski F-Score	n/a